The Pierce phosphatase inhibitor mini tablets protect phosphoproteins from serine/ threonine phosphatases and tyrosine phosphatases.
The Pierce phosphatase inhibitor mini tablets protect phosphoproteins from serine/ threonine phosphatases and tyrosine phosphatases. Each phosphatase inhibitor tablet contains sodium fluoride, sodium l-orthovanadate, sodium pyrophosphate, and beta-glycerophosphate for broad spectrum inhibition of phosphatase activity. The tablets are stable at 4°C for 12 months and each tablet is sufficient for 10 ml of solution. Pierce phosphatase inhibitor tablets are suitable for use with all cell or tissue extracts to preserve protein phosphorylation for downstream applications.
Economic
Economic: Better cost-effectiveness than other market options.
Improved formulation
Improved formulation: rapid dissolution of tablets and a transparent solution.
Complete
Complete: inhibition of acidic and alkaline phosphatases and protein phosphatases.
Compatible
Compatible: use with internally developed or commercially available cellular lysis reagents and with Thermo Scientific protein assays.
Technical specifications
| General |
| Brand | Thermo Scientific |
| Supplier ref. (Fisher Scientific) | 15691759 |
| Specifications |
| Product type | Inhibitor |
| Shape | Solid |
| Product range | Pierce™ |
| Sufficient for | 10 ml solution |
| Inhibitors | Phosthase inhibitor |
| Quantity | 20 tablets |
| Composition | Sodium fluoride, sodium orthovanadate, sodium pyrophosphate, beta-glycerophosphate |
| Storage and shipping |
| Content and storage | 1 vial, store between 2°C and 8°C |
| Shipping conditions | Moist ice |
A question or a specific configuration?
Contact us for a quote.